BioMarin Pharmaceutical - PDFSEARCH.IO - Document Search Engine

BioMarin Pharmaceutical
Results: 48

#	Item
11	Clinical Commissioning Policy Statement: Amifampridine (Firdapse) for Lambert Easton Myasthenic Syndrome (LEMS) April 2013 Add to Reading List Source URL: www.england.nhs.uk Language: English - Date: 2014-08-12 08:05:40 3 4-Diaminopyridine Pyridines Lambert–Eaton myasthenic syndrome BioMarin Pharmaceutical Small-cell carcinoma NHS Constitution for England National Health Service Scottish Medicines Consortium Medicine Health Paraneoplastic syndromes
12	SuperGen President & CEO Elected to BIO Board of Directors DUBLIN, Calif., Jun 28, 2011 (BUSINESS WIRE) -SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer t Add to Reading List Source URL: astx.com Language: English
13	TLC Technologies, Inc. Company Overview Thomas F. Foley President Mr. Foley founded TLC Technologies in 1997 after Add to Reading List Source URL: www.tlctechnologies.net Language: English - Date: 2013-02-13 19:10:46 TM1 Enterprise performance management Keane Business intelligence BioMarin Pharmaceutical Cognos Data management Online analytical processing Management Business
14	July 30, 2014 Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission TARRYTOWN, N.Y. and PARIS, July 30, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Add to Reading List Source URL: files.shareholder.com Language: English Regeneron Pharmaceutical industry Food and Drug Administration Priority review voucher BioMarin Pharmaceutical Monoclonal antibodies Sanofi Pharmaceutical sciences Pharmacology Clinical research
15	PDF Document Add to Reading List Source URL: www.england.nhs.uk Language: English - Date: 2013-08-13 12:09:51 3 4-Diaminopyridine Pyridines Lambert–Eaton myasthenic syndrome BioMarin Pharmaceutical Small-cell carcinoma NHS Constitution for England National Health Service Scottish Medicines Consortium NHS Scotland Medicine Health Paraneoplastic syndromes
16	BioMarin Pharmaceutical Inc.; Rule 14a-8 no-action letter Add to Reading List Source URL: www.sec.gov Language: English - Date: 2014-03-19 12:42:46 Statements Stock market BioMarin Pharmaceutical Shareholder resolution Annual general meeting Business Finance Economics SEC filings Corporate governance Proxy statement
17	Contacts: Investors Traci McCarty BioMarin Pharmaceutical Inc[removed] Add to Reading List Source URL: files.shareholder.com Language: English Genetic genealogy BioMarin Pharmaceutical Duchenne muscular dystrophy Dystrophin 3 4-Diaminopyridine Mucopolysaccharidosis Morquio syndrome Tetrahydrobiopterin Muscular dystrophy Health Biology
18	Annual Exercise With so many interconnected stakeholders the bio-pharmaceutical supply chain faces unique challenges during disasters - even localized disruptions can have widespread consequences. The Rx Response Annual Add to Reading List Source URL: www.rxresponse.org Language: English - Date: 2014-09-07 21:37:35 BioMarin Pharmaceutical Companies listed on the New York Stock Exchange AmerisourceBergen Public Readiness and Emergency Preparedness Act
19	Review - Laronidase (Aldurazyme) Add to Reading List Source URL: www.fda.gov Language: English Mucopolysaccharidosis Hurler syndrome Iduronidase Lysosomal storage disease Coarse facial features BioMarin Pharmaceutical Enzyme replacement therapy Hurler–Scheie syndrome Methadone Health Syndromes Medicine
20	Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine, Adsorbed (Infanrix) - Review Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutics Science Clinical research Food and Drug Administration Quality Validation BioMarin Pharmaceutical Form FDA 483 Verification and validation Pharmaceutical industry Validity Pharmaceutical sciences